SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Recruiting
N/A
Interventional Study
Gastrointestinal Cancer
Hematologic Cancer
Thoracic Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 210 (estimated)
- Sponsor
- Nadine McCleary, MD, MPH · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
SURGE aims to increase equity in clinical trial enrollment by addressing barriers to genomic testing, which is increasingly needed to assess precision clinical trial eligibility and access standard precision therapies. The study is an interventional pilot meant primarily to assess the feasibility of the intervention. The intervention is comprised of a patient navigator, text message questionnaire,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult (age 18 years or older)
* Black, Latinx, OR older adult (age 70 years or older)
* Scheduled for a new patient consultation
* Suspected or confirmed advanced malignancy (requiring active treatment)
* Gastrointestinal, hematologic, or thoracic cancer
* DFCI patient at Long…
Contacts
Nadine J McCleary, MD MPH
(617) 632-6729
CONTACT